KLK3 and cancer: The median age at the time of surgery was 62.8 years (IQR 57.2–67.1 years), the median PSA was 6.5 ng/mL at the time of diagnosis (IQR 4.4–9.5 ng/mL), and the majority of patients (61.2%, n = 300) had cancer confined within the prostate.